Oxford Instruments PLC Trading Statement (8302V)
April 11 2019 - 2:00AM
UK Regulatory
TIDMOXIG
RNS Number : 8302V
Oxford Instruments PLC
11 April 2019
Oxford Instruments plc
Trading Update 11 April 2019
Oxford Instruments plc, a leading provider of high technology
products and services to industrial companies and scientific
research communities, is today issuing a trading update.
As predicted, trading in the second half of the year was
supported by a strong order book and our normal second half
seasonal bias. We expect adjusted operating profit for the full
year to be around the higher end of expectations(1) , despite a
small adverse currency effect.
A good cash conversion during the year has resulted in the Group
achieving a positive net cash position as at 31 March 2019.
Oxford Instruments' results for the year ended 31 March 2019
will be released on 11 June 2019.
(1) Oxford Instruments compiled analyst forecast range for
adjusted operating profit (year to 31 March 2019): GBP46.0m to
GBP49.2m
Enquiries:
Oxford Instruments plc Tel: 01865 393200
Ian Barkshire, Chief Executive
Gavin Hill, Group Finance Director
MHP Communications Tel: 020 3128 8100
Rachel Hirst/Luke Briggs
- Ends -
Issued for and on behalf of Oxford Instruments plc
Notes to Editors
About Oxford Instruments plc
Oxford Instruments designs, supplies and supports
high-technology tools and systems with a focus on research and
industrial applications. Innovation has been the driving force
behind Oxford Instruments' growth and success for over 50 years,
and its strategy is to effect the successful commercialisation of
these ideas by bringing them to market in a timely and
customer-focused fashion.
The first technology business to be spun out from Oxford
University, Oxford Instruments is now a global company and is
listed on the London Stock Exchange (OXIG). Its objective is to be
the leading provider of new generation tools and systems for the
research and industrial sectors with a focus on nanotechnology. Its
key market sectors include nano-fabrication and nano-materials. The
company's strategy is to expand the business into the life sciences
arena, where nanotechnology and biotechnology intersect.
This involves the combination of core technologies in areas such
as low temperature and high magnetic field environments; Nuclear
Magnetic Resonance; X-ray, electron, laser and optical based
metrology; atomic force microscopy; optical imaging; advanced
growth, deposition and etching.
Oxford Instruments aims to pursue responsible development and
deeper understanding of our world through science and technology.
Its products, expertise, and ideas address global issues such as
energy, environment, security and health.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TSTDBLFFKZFEBBE
(END) Dow Jones Newswires
April 11, 2019 02:00 ET (06:00 GMT)
Oxford Instruments (LSE:OXIG)
Historical Stock Chart
From Apr 2024 to May 2024
Oxford Instruments (LSE:OXIG)
Historical Stock Chart
From May 2023 to May 2024